Combining immune checkpoint inhibitors for advanced melanoma: the key to optimizing treatment outcomes?

被引：0
作者：
Freeston, Sarah [1 ]
机构：
[1] UCL, Sch Med, Gower St, London, England
来源：
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH | 2016年 / 5卷 / 04期
关键词：
CTLA-4; immunotherapy; ipilimumab; melanoma; nivolumab; PD-1; IPILIMUMAB PLUS DACARBAZINE; T-CELLS; NIVOLUMAB; PEMBROLIZUMAB; CHEMOTHERAPY; ANTI-CTLA-4; CTLA-4;
D O I：
10.2217/cer-2016-0023
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：329 / 333
页数：5
相关论文
共 25 条
  • [1] Ascierto PA, 2011, J MOL BIOMARK DIAGN, V2, p102e
  • [2] Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort
    Ascierto, Paolo A.
    Simeone, Ester
    Sileni, Vanna Chiarion
    Pigozzo, Jacopo
    Maio, Michele
    Altomonte, Maresa
    Del Vecchio, Michele
    Di Guardo, Lorenza
    Marchetti, Paolo
    Ridolfi, Ruggero
    Cognetti, Francesco
    Testori, Alessandro
    Bernengo, Maria Grazia
    Guida, Michele
    Marconcini, Riccardo
    Mandala, Mario
    Cimminiello, Carolina
    Rinaldi, Gaetana
    Aglietta, Massimo
    Queirolo, Paola
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [3] Final Version of 2009 AJCC Melanoma Staging and Classification
    Balch, Charles M.
    Gershenwald, Jeffrey E.
    Soong, Seng-jaw
    Thompson, John F.
    Atkins, Michael B.
    Byrd, David R.
    Buzaid, Antonio C.
    Cochran, Alistair J.
    Coit, Daniel G.
    Ding, Shouluan
    Eggermont, Alexander M.
    Flaherty, Keith T.
    Gimotty, Phyllis A.
    Kirkwood, John M.
    McMasters, Kelly M.
    Mihm, Martin C., Jr.
    Morton, Donald L.
    Ross, Merrick I.
    Sober, Arthur J.
    Sondak, Vernon K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) : 6199 - 6206
  • [4] PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
    Curran, Michael A.
    Montalvo, Welby
    Yagita, Hideo
    Allison, James P.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (09) : 4275 - 4280
  • [5] Combination Therapy with Anti-CTLA-4 and Anti-PD-1 Leads to Distinct Immunologic Changes In Vivo
    Das, Rituparna
    Verma, Rakesh
    Sznol, Mario
    Boddupalli, Chandra Sekhar
    Gettinger, Scott N.
    Kluger, Harriet
    Callahan, Margaret
    Wolchok, Jedd D.
    Halaban, Ruth
    Dhodapkar, Madhav V.
    Dhodapkar, Kavita M.
    [J]. JOURNAL OF IMMUNOLOGY, 2015, 194 (03) : 950 - 959
  • [6] Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system
    de Coana, Yago Pico
    Choudhury, Aniruddha
    Kiessling, Rolf
    [J]. TRENDS IN MOLECULAR MEDICINE, 2015, 21 (08) : 482 - 491
  • [7] International trends in the incidence of malignant melanoma 1953-2008uare recent generations at higher or lower risk?
    Erdmann, Friederike
    Lortet-Tieulent, Joannie
    Schuez, Joachim
    Zeeb, Hajo
    Greinert, Ruediger
    Breitbart, Eckhard W.
    Bray, Freddie
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (02) : 385 - 400
  • [8] A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naive patients with advanced melanoma
    Hersh, Evan M.
    O'Day, Steven J.
    Powderly, John
    Khan, Khuda D.
    Pavlick, Anna C.
    Cranmer, Lee D.
    Samlowski, Wolfram E.
    Nichol, Geoffrey M.
    Yellin, Michael J.
    Weber, Jeffrey S.
    [J]. INVESTIGATIONAL NEW DRUGS, 2011, 29 (03) : 489 - 498
  • [9] An open-label, randomized, phase 2 study of nivolumab (NIVO) given sequentially with ipilimumab (IPI) in patients with advanced melanoma (CheckMate 064)
    Hodi, F. S.
    Gibney, G.
    Sullivan, R.
    Sosman, J. A.
    Slingluff, C. L., Jr.
    Lawrence, D. P.
    Logan, T. F.
    Schuchter, L. M.
    Nair, S.
    Fecher, L.
    Buchbinder, E.
    Ruisi, M.
    Kong, G.
    Horak, C.
    Weber, J. S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S721 - S721
  • [10] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    O'Day, Steven J.
    McDermott, David F.
    Weber, Robert W.
    Sosman, Jeffrey A.
    Haanen, John B.
    Gonzalez, Rene
    Robert, Caroline
    Schadendorf, Dirk
    Hassel, Jessica C.
    Akerley, Wallace
    van den Eertwegh, Alfons J. M.
    Lutzky, Jose
    Lorigan, Paul
    Vaubel, Julia M.
    Linette, Gerald P.
    Hogg, David
    Ottensmeier, Christian H.
    Lebbe, Celeste
    Peschel, Christian
    Quirt, Ian
    Clark, Joseph I.
    Wolchok, Jedd D.
    Weber, Jeffrey S.
    Tian, Jason
    Yellin, Michael J.
    Nichol, Geoffrey M.
    Hoos, Axel
    Urba, Walter J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) : 711 - 723
123